🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro KwikPen vs vial — looking for input Page 4

Mounjaro KwikPen vs vial — looking for input

tony_orlando Sat, Oct 19, 2024 at 1:14 AM 33 replies 2,392 viewsPage 4 of 7
oliver_london
Member
312
1,345
Aug 2024
London, UK
Oct 24, 2024 at 7:03 AM#16
pat_auckland said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Same experience, arrived at from the opposite direction. Nothing to add that would improve it.

45 18Admin, Dr.Martinez, mike_mod and 42 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Oct 24, 2024 at 6:56 PM#17
PeptideSynthNJ said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Coming at PeptideSynthNJ’s question from a different direction. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

46 19Dr.PulmRoch, maya_sedona, stefan_berlin and 43 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Oct 25, 2024 at 6:49 AM#18

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Oct 25, 2024 at 9:49 AM
47 20DataDave, Dr.GutHealth, amsterdam_pete and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Oct 25, 2024 at 6:43 PM#19

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

48 21MikeFit_NJ, InsuranceTom, WendyG_ATL and 45 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Oct 26, 2024 at 6:37 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Tagging this one for the weekly digest.

20 18PurityPaulOR, MaxMetOK, MounjBrad and 17 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register